Greenway L. Schond's most recent trade in Mind Medicine Inc was a trade of 5,560 Common Shares done at an average price of $9.8 . Disclosure was reported to the exchange on March 25, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mind Medicine Inc | Schond L. Greenway | Chief Financial Officer | 25 Mar 2024 | 5,560 | 211,057 | - | 9.8 | 54,377 | Common Shares | |
Mind Medicine Inc | Greenway L. Schond | Chief Financial Officer | 27 Feb 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | ||
Avalo Therapeutics Inc | Schond L. Greenway | CFO | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 10 Dec 2021 | 2,231 | 3,883 | - | 1.6 | 3,503 | Common Stock |
Avalo Therapeutics Inc | Schond L. Greenway | CFO | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 10 Jun 2021 | 652 | 1,652 | - | 2.7 | 1,747 | Common Stock |
Avalo Therapeutics Inc | Schond L. Greenway | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |